Citation Impact
Citing Papers
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
Longitudinal assessment of antimüllerian hormone during pregnancy—relationship with maternal adiposity, insulin, and adiponectin
2009
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status
2005
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation
2010
Wearable biosensors for healthcare monitoring
2019 Standout
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
2014
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
2004
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
2007
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
2011
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
A Functional Anti-Müllerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients
2008
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
2010
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism
2005
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history
2012
Diagnosis and treatment of polycystic ovarian syndrome in adolescents
2012
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
2011
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
2008
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts
2009
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route
2012
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
2011
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
2008
Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
2011
Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture
2007
Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve
2009
Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?
2011
Fertility and infertility: Definition and epidemiology
2018 Standout
Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
2006
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
2004
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique—a prospective, randomized, double-blind study
2006
Association of anti-mullerian hormone levels with obesity in late reproductive-age women
2006
The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
2013
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model
2012
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
2005
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause
2013
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
The phenotype of polycystic ovary syndrome ameliorates with aging
2011
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
2005
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
2013
Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
2017
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Müllerian hormone and ovarian dysfunction
2008
A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause
2009
Effect of Obesity on Parameters of Ovarian Reserve in Premenopausal Women
2010
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
2010
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
2013
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Anti-Mullerian hormone: a new marker for ovarian function
2005
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
2016
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
2012
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age‐matched controls
2013
Role of Oxidative Stress in Polycystic Ovary Syndrome
2010
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
2010
Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries
2005
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
2007
Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mullerian Hormone Null Mice
2007
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
2007
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
2016
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women
2007
Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome
2008
Works of E. Merlen being referenced
Révélation d’un syndrome des ovaires polymicrokystiques après un mois de traitement par GnRH pulsatile chez une patiente présentant une aménorrhée hypothalamique fonctionnelle
2003
Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement
2015
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
2003